You are here

  • Home
  • Archive
  • Volume 21, Issue 4
  • Phase II Evaluation of Phenoxodiol in Combination With Cisplatin or Paclitaxel in Women With Platinum/Taxane-Refractory/Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Phase II Evaluation of Phenoxodiol in Combination With Cisplatin or Paclitaxel in Women With Platinum/Taxane-Refractory/Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 20191600
Apr 20192501
May 20192500
Jun 20191200
Jul 20193202
Aug 20193001
Sep 20192800
Oct 20191700
Nov 20192300
Dec 20191300
Jan 20201600
Feb 20203201
Mar 2020700
Apr 20202400
May 20201900
Jun 20202600
Jul 20202602
Aug 20201800
Sep 20202101
Oct 20201400
Nov 2020600
Dec 20201700
Jan 20211800
Feb 20212400
Mar 20211203
Apr 20212600
May 2021300
Jun 2021100
Jul 2021500
Aug 2021600
Sep 2021201
Oct 20214500
Nov 20213400
Dec 20211400
Jan 20223300
Feb 20221800
Mar 20222800
Apr 20222700
May 20224200
Jun 20223800
Jul 20226000
Aug 20225000
Sep 20226400
Oct 20223400
Nov 20225501
Dec 20222700
Jan 20234000
Feb 20236200
Mar 20233901
Apr 20231400
May 20231401
Jun 20231800
Jul 20231200
Aug 20232002
Sep 20233000
Oct 20232001
Nov 20233800
Dec 20234601
Jan 20241800
Feb 20241400
Mar 20246001
Apr 20241500
Total1573020